Skip to content. | Skip to navigation

Garvan Institute

Sections
 

Garvan Breakthroughs

1993-1994 - Discovered the role of cyclins in breast cancer (one of the top 20 advances in breast cancer in a decade)

Donate Now

Please help us continue our breakthrough medical research

Quick Facts

  • Approximately 12 000 women are diagnosed with breast cancer in Australia each year

Cancer Survival Rates

If you were diagnosed with cancer today, what would your chances of survival be?

Ongoing medical research over the last 2 decades has seen the cancer survival rate of many common cancers increase by over 30%. However cancer remains a major cause of death in Australia.

For details of the survival rates of various cancers, please click here
 

Cancer - Breast

 
Cancer - Breast

Breast cancer is the most common cancer in Australian women. It is also the primary cause of female cancer deaths, with one in 11 Australian women developing breast cancer before the age of 75 years.

Although the incidence of breast cancer is still on the rise, more Australian women are surviving breast cancer than ever before; 85% of women diagnosed with breast cancer can expect to still be alive five years after diagnosis. Significant advances in the early detection and treatment of breast cancer mean that more women are surviving the disease than ever before.


 
Nine out of ten women who develop breast cancer do not have a family history of the disease.
 

Download Fact Sheet

News

 

Glimpse the future of medical research at Garvan Open Day

MEDIA RELEASE: 18 Jul 2008
Garvan will open its doors on Sunday 17th August from 10am to 1pm for Open Day, giving the public the opportunity to meet and talk with leading scientists and learn about the future of science and medicine from some of the sharpest minds in Australia.
 
 

Garvan cancer researcher wins Premier's Award

18 Jun 2008
Garvan researcher Rebecca Hinshelwood received the highly coveted $10,000 Premier’s Award for Outstanding Cancer Research Scholar at a gala ceremony last month. The award, from the Cancer Institute of NSW, is a form of educational scholarship.
 
 

Targeting aggressive breast cancers by putting them to sleep

MEDIA RELEASE: 25 Mar 2008
Dr Alex Swarbrick, head of Garvan's Tumour Progression Research Group, has published findings that Id1, a gene produced by the most aggressive forms of breast cancer, can control breast cancer growth. He has shown that by 'switching off' the Id1 gene, it is possible to induce a state of 'senescence', or permanent sleep, within a tumour, preventing it from growing or spreading.
 
 

Personal tools